Atrial fibrillation: diagnosis and management-summary of NICE guidance

BMJ. 2021 May 21:373:n1150. doi: 10.1136/bmj.n1150.

Authors

Mark Perry¹, Sophia Kemmis Betty², Nicole Downes², Neil Andrews³, Simon Mackenzie⁴; Guideline Committee

Collaborators

Guideline Committee:
Neil Andrews, Matthew Bates, Antony Chuter, Nazish Khan, Paulus Kirchhof, Geraldine Lee, Simon Mackenzie, Thomas McAnea, Irene McGill, Chakravarthi Rajkumar, Yohan Samarasinghe, Jaspal Taggar, Keith Tyndall

Affiliations

¹ National Guideline Centre, Royal College of Physicians, London NW1 4LE, UK mark.perry@rcp.ac.uk.
² National Guideline Centre, Royal College of Physicians, London NW1 4LE, UK.
³ Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
⁴ NHS England and NHS Improvement, UK.

PMID: 34020968
DOI: 10.1136/bmj.n1150

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Ablation Techniques / methods*
Anticoagulants / therapeutic use
Atrial Fibrillation / complications
Atrial Fibrillation / diagnosis
Atrial Fibrillation / therapy*
Catheter Ablation / methods
Clinical Decision Rules
Cryosurgery / methods
Factor Xa Inhibitors / therapeutic use*
Hemorrhage / chemically induced*
Hemorrhage / prevention & control
Humans
Laser Therapy / methods
Practice Guidelines as Topic*
Risk Assessment
Stroke / etiology
Stroke / prevention & control*
United Kingdom
Warfarin / therapeutic use

Substances

Anticoagulants
Factor Xa Inhibitors
Warfarin